Annals of Clinical Microbiology, The official Journal of the Korean Society of Clinical Microbiology

6

Weeks in Review

4

Weeks to Publication
Indexed in KCI, KoreaMed, Synapse, DOAJ
Open Access, Peer Reviewed
pISSN 2288-0585 eISSN 2288-6850

Table 2. New EUCAST v.12.0 clinical breakpoint organism-antimicrobial agent for anaerobic bacteria

Ann Clin Microbiol 2022;25:67-72. EUCAST v.12.0 review focused on changes Download table Organism Antimicrobial agent Bacteroides spp. Piperacillin-tazobactam, Meropenem, Clindamycin, Metronidazole Prevotella spp. Benzylpenicillin, Piperacillin-tazobactam, Meropenem, Clindamycin, Metronidazole F. necrophorum Benzylpenicillin, Piperacillin-tazobactam, Meropenem, Clindamycin, Metronidazole C. perfringens Benzylpenicillin, Piperacillin-tazobactam, Meropenem, Vancomycin, Clindamycin, Metronidazole C. acnes Benzylpenicillin, Piperacillin-tazobactam, Meropenem, Vancomycin, Clindamycin C. difficile Vancomycin, Metronidazole, Fidaxomicin […]

Table 3. Revised EUCAST v.12.0 clinical breakpoints

Ann Clin Microbiol 2022;25:67-72. EUCAST v.12.0 review focused on changes Download table (A) Disk diffusion method: revised zone diameter breakpoints (mm), ATU Organism Antimicrobial agent S ≥ R < ATU P. aeruginosa Meropenem (indications other than meningitis) 20 14 – Meropenem (meningitis) 20 20 Pseudomonasspp. Levofloxacin 50 18 S. epidermidisand S.lugdunensis Cefoxitin (screen only) 27 […]

Table 1. Resistance to carbapenem and ciprofloxacin with corresponding resistance genes

Ann Clin Microbiol 2022;25:53-59. Current prevalence of the crpP gene in carbapenemase-producing Pseudomonas aeruginosa blood isolates in Korea Download table Isolates Phenotype (ZD) Genotype IPM MEM CIP CRP PMQR gyrA parC F0020PA0023 R (11) R (10) R (6) blaGES-9 aac(6′)-Ib-cr Thr83Ile Ser87Leu A0020PA0022 R (7) R (6) R (6) blaGES-5 aac(6′)-Ib-cr, crpP Thr83Ile Ser87Leu A0020PA0005 […]

Table 1. Comparison between CA-CDI and HA-CDI groups

Ann Clin Microbiol 2022;25:47-52. Clinical and microbiological risk factors for community-associated Clostridioides difficile infections Download table Variables CA-CDI (n = 127) HA-CDI (n = 265) P-value Age (yr) 66.9±18.9 72.1±13.5 0.0064 Sex, male 51 (40.2) 120 (45.3) 0.3386 Charlson comorbidity index 2.4±2.1 2.7±1.9 0.1109 Associated disease Biliary tract disease 3 (2.4) 8 (3.0) 0.7133 Cancer […]

Table 2. Patient characteristics of four cases with UL54 mutations alone

Ann Clin Microbiol 2022;25:41-46. Antiviral resistance in human cytomegalovirus due to UL54 mutations without UL97 mutations Download table Patient No. Sex Age (yr) Underlying disease CMV disease Outcome UL54 mutations 6 Female 15 MDS, HaploPBSCT Pneumonia Retinitis Encephalitis Expired F412L 11 Female 18 AA, HaploPBSCT Pneumonia Encephalitis Expired V715M/L501I 14 Female 18 AA, HaploPBSCT Encephalitis […]

Table 1. Human cytomegalovirus UL97/UL54 gene mutations observed in this study

Ann Clin Microbiol 2022;25:41-46. Antiviral resistance in human cytomegalovirus due to UL54 mutations without UL97 mutations Download table Case No. Year UL97 mutations (specimen) UL54 mutations (specimen) Viral loads 3 2019 A594P (blood) – 4.12 log IU/mL 6 2018 – F412L (blood) 3.03 log IU/mL 7 2018 L595F (blood) N408D (blood) 4.40 log copies/mL 11 […]

Table 2. Risk factors for severe or severe complicated CDI over non-severe CDI: a multivariate analysis

Ann Clin Microbiol 2022;25:17-23. Clinical and microbiological risk factors for severe Clostridioides difficile infections Download table Risk factor OR (95% CI) P-value* Advanced age 1.017 (1.001-1.034) 0.0358 History of chemotherapy 2.695 (1.016-7.146) 0.0464 Ribotype 002 3.406 (1.183-9.803) 0.0231 *Statistical significances were maintained after the adjustment for age, associated disease (cancer, pneumonia, heart failure, nutrition deficiency), […]